Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

kneat.com

DB:FOBK
Snowflake Description

Flawless balance sheet with limited growth.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
FOBK
DB
CA$112M
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

kneat.com, inc. designs, develops, and supplies software for data and document management within regulated environments in the United States, the United Kingdom, Romania, Ireland, and Canada. The last earnings update was 125 days ago. More info.


Add to Portfolio Compare Print
  • kneat.com has significant price volatility in the past 3 months.
FOBK Share Price and Events
7 Day Returns
26.3%
DB:FOBK
4.1%
DE Healthcare Services
7.3%
DE Market
1 Year Returns
31.2%
DB:FOBK
0.9%
DE Healthcare Services
-17.7%
DE Market
FOBK Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
kneat.com (FOBK) 26.3% -23.4% -35.7% 31.2% 207.7% -
DE Healthcare Services 4.1% -8.3% -18.1% 0.9% 24.9% 85.3%
DE Market 7.3% -17.9% -25.8% -17.7% -25.6% -29%
1 Year Return vs Industry and Market
  • FOBK outperformed the Healthcare Services industry which returned 0.9% over the past year.
  • FOBK outperformed the Market in Germany which returned -17.7% over the past year.
Price Volatility
FOBK
Industry
5yr Volatility vs Market
Related Companies

Sorry, no analysis for kneat.com's competitors could be found in our database.

FOBK Value

 Is kneat.com undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for kneat.com. This is due to cash flow or dividend data being unavailable. The share price is €1.08.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for kneat.com's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are kneat.com's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:FOBK PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in CAD CA$-0.10
TSXV:KSI Share Price ** TSXV (2020-03-30) in CAD CA$1.77
Germany Healthcare Services Industry PE Ratio Median Figure of 6 Publicly-Listed Healthcare Services Companies 11.1x
Germany Market PE Ratio Median Figure of 400 Publicly-Listed Companies 16.36x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of kneat.com.

DB:FOBK PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSXV:KSI Share Price ÷ EPS (both in CAD)

= 1.77 ÷ -0.10

-17.56x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • kneat.com is loss making, we can't compare its value to the DE Healthcare Services industry average.
  • kneat.com is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does kneat.com's expected growth come at a high price?
Raw Data
DB:FOBK PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -17.56x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts
81%per year
Europe Healthcare Services Industry PEG Ratio Median Figure of 14 Publicly-Listed Healthcare Services Companies 2.29x
Germany Market PEG Ratio Median Figure of 254 Publicly-Listed Companies 1.2x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for kneat.com, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on kneat.com's assets?
Raw Data
DB:FOBK PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in CAD CA$0.20
TSXV:KSI Share Price * TSXV (2020-03-30) in CAD CA$1.77
Germany Healthcare Services Industry PB Ratio Median Figure of 7 Publicly-Listed Healthcare Services Companies 2.88x
Germany Market PB Ratio Median Figure of 574 Publicly-Listed Companies 1.43x
DB:FOBK PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSXV:KSI Share Price ÷ Book Value per Share (both in CAD)

= 1.77 ÷ 0.20

8.84x

* Primary Listing of kneat.com.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • kneat.com is overvalued based on assets compared to the DE Healthcare Services industry average.
X
Value checks
We assess kneat.com's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. kneat.com has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

FOBK Future Performance

 How is kneat.com expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
81%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is kneat.com expected to grow at an attractive rate?
  • Unable to compare kneat.com's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.
Growth vs Market Checks
  • Unable to compare kneat.com's earnings growth to the Germany market average as it is expected to be loss making during the next 1-3 years.
  • kneat.com's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:FOBK Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:FOBK Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts 81%
DB:FOBK Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 2 Analysts 69.8%
Europe Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 28.6%
Europe Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 8.5%
Germany Market Earnings Growth Rate Market Cap Weighted Average 14.3%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:FOBK Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:FOBK Future Estimates Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-12-31 15 1
2020-12-31 9 -2 2
2020-03-30
2019-12-31 4 -7 2
DB:FOBK Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-09-30 3 -2 -6
2019-06-30 2 -2 -6
2019-03-31 1 -3 -6
2018-12-31 1 -4 -5
2018-09-30 1 -3 -5
2018-06-30 1 -3 -4
2018-03-31 1 -4 -4
2017-12-31 0 -3 -4
2017-09-30 1 -2 -3
2017-06-30 1 -2 -3
2017-03-31 1 -2 -7
2016-12-31 1 -2 -7

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • kneat.com is not considered high growth as it is expected to be loss making for the next 1-3 years.
  • kneat.com's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:FOBK Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below

All data from kneat.com Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:FOBK Future Estimates Data
Date (Data in CAD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-12-31
2020-12-31 -0.03 -0.03 -0.03 1.00
2020-03-30
2019-12-31 -0.11 -0.11 -0.11 1.00
DB:FOBK Past Financials Data
Date (Data in CAD Millions) EPS *
2019-09-30 -0.10
2019-06-30 -0.12
2019-03-31 -0.12
2018-12-31 -0.09
2018-09-30 -0.10
2018-06-30 -0.09
2018-03-31 -0.08
2017-12-31 -0.09
2017-09-30 -0.08
2017-06-30 -0.07
2017-03-31 -0.20
2016-12-31 -0.21

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if kneat.com will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess kneat.com's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
kneat.com has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

FOBK Past Performance

  How has kneat.com performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare kneat.com's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • kneat.com does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare kneat.com's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare kneat.com's 1-year growth to the DE Healthcare Services industry average as it is not currently profitable.
Earnings and Revenue History
kneat.com's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from kneat.com Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:FOBK Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 3.01 -5.70 3.26 3.15
2019-06-30 1.65 -6.29 3.09 2.94
2019-03-31 1.26 -6.02 2.93 2.71
2018-12-31 1.31 -4.61 2.94 2.56
2018-09-30 0.92 -5.01 2.15 3.44
2018-06-30 0.80 -4.21 2.15 2.80
2018-03-31 0.74 -3.71 2.31 2.31
2017-12-31 0.42 -3.99 2.41 1.76
2017-09-30 1.05 -3.42 3.33
2017-06-30 1.00 -2.94 3.18
2017-03-31 0.95 -7.15 2.91
2016-12-31 0.82 -7.02 2.68
2016-09-30 0.46 -6.89 2.50
2016-06-30 0.67 -6.39 2.07
2016-03-31 0.83 -1.46 1.68
2015-12-31 0.99 -1.01 1.44
2014-12-31 0.28 -1.13 1.26 -0.22
2013-12-31 -11.80 11.37 -1.74

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if kneat.com has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if kneat.com has efficiently used its assets last year compared to the DE Healthcare Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if kneat.com improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess kneat.com's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
kneat.com has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

FOBK Health

 How is kneat.com's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up kneat.com's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • kneat.com is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • kneat.com's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of kneat.com's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 9.5x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from kneat.com Company Filings, last reported 6 months ago.

DB:FOBK Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 12.02 0.86 6.96
2019-06-30 12.85 0.93 7.69
2019-03-31 14.05 0.99 9.38
2018-12-31 7.59 1.03 2.77
2018-09-30 8.53 0.98 4.01
2018-06-30 10.25 1.00 5.89
2018-03-31 5.94 1.03 2.06
2017-12-31 6.61 0.99 3.48
2017-09-30 7.63 0.96 4.53
2017-06-30 8.68 0.97 6.08
2017-03-31 6.54 0.93 4.88
2016-12-31 7.29 0.92 4.99
2016-09-30 7.60 0.96 6.13
2016-06-30 8.13 0.94 7.30
2016-03-31 2.24 0.97 1.06
2015-12-31 2.24 0.97 1.06
2014-12-31 0.52 1.19 0.02
2013-12-31 0.80 1.03 0.73
  • kneat.com's level of debt (7.2%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (195.4% vs 7.2% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • kneat.com has sufficient cash runway for 1.2 years based on current free cash flow.
  • kneat.com has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of -7.8% each year.
X
Financial health checks
We assess kneat.com's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. kneat.com has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

FOBK Dividends

 What is kneat.com's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from kneat.com dividends.
If you bought €2,000 of kneat.com shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate kneat.com's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate kneat.com's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:FOBK Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
Europe Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 11 Stocks 1.7%
Germany Market Average Dividend Yield Market Cap Weighted Average of 323 Stocks 3.9%
Germany Minimum Threshold Dividend Yield 10th Percentile 1%
Germany Bottom 25% Dividend Yield 25th Percentile 1.7%
Germany Top 25% Dividend Yield 75th Percentile 5%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:FOBK Future Dividends Estimate Data
Date (Data in CA$) Dividend per Share (annual) Avg. No. Analysts
2021-12-31
2020-12-31
2020-03-30
2019-12-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as kneat.com has not reported any payouts.
  • Unable to verify if kneat.com's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of kneat.com's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as kneat.com has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess kneat.com's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can kneat.com afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. kneat.com has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

FOBK Management

 What is the CEO of kneat.com's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Eddie Ryan
COMPENSATION CA$186,439
AGE 55
CEO Bio

Mr. Edmund Ryan, also known as Eddie, serves as the Chief Executive Officer, President and Sales Director of Kneat.com, Inc. and has been its Executive Director since June 27, 2017. Mr. Ryan has experience in design, production and project management within pharmaceutical manufacturing and in regulated IT development and Sales to Life Sciences. He has managed multidisciplinary pharmaceutical projects on behalf of blue-chip companies. Eddie also headed Irish sales for multinational manufacturers of capital and consumable pharmaceutical equipment. He served as a Director of Fortune Bay Corp. since June 15, 2016. He is a Mechanical Engineer with a Diploma in Sales and Marketing. Mr. Ryan holds a Bachelor of Engineering in Mechanical Engineering from the University of Limerick and a Post Graduate Diploma in International Sales and Marketing from the Dublin Institute Technology.

CEO Compensation
  • Eddie's compensation has increased whilst company is loss making.
  • Eddie's remuneration is lower than average for companies of similar size in Germany.
Management Team

Eddie Ryan

TITLE
Co-Founder
COMPENSATION
CA$186K
AGE
55

Brian Ahearne

TITLE
Co-Founder
COMPENSATION
CA$162K
AGE
50

Kevin Fitzgerald

TITLE
Co-Founder
COMPENSATION
CA$162K
AGE
49

Hugh Kavanagh

TITLE
Chief Financial Officer
AGE
57
TENURE
0.5 yrs
Board of Directors Tenure

Average tenure and age of the kneat.com board of directors in years:

3.8
Average Tenure
55
Average Age
  • The tenure for the kneat.com board of directors is about average.
Board of Directors

Ian Ainsworth

TITLE
Chairman
COMPENSATION
CA$38K
AGE
68

Eddie Ryan

TITLE
Co-Founder
COMPENSATION
CA$186K
AGE
55
TENURE
3.8 yrs

Kevin Fitzgerald

TITLE
Co-Founder
COMPENSATION
CA$162K
AGE
49
TENURE
3.8 yrs

Paul Breen

TITLE
Independent Director
COMPENSATION
CA$38K
AGE
62
TENURE
3.8 yrs

Wade Dawe

TITLE
Director
COMPENSATION
CA$38K
AGE
49
TENURE
6.2 yrs

Rory Cameron

TITLE
Non Executive Independent Director
TENURE
0.8 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by kneat.com individual insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
24. Mar 20 Buy Brigus Capital Incorporated Company 23. Mar 20 23. Mar 20 5,498 €0.76 €4,188
24. Mar 20 Buy Wade Dawe Individual 23. Mar 20 23. Mar 20 10,000 €0.77 €7,661
24. Mar 20 Buy Ian Ainsworth Individual 23. Mar 20 23. Mar 20 15,000 €0.77 €11,443
18. Mar 20 Buy Wade Dawe Individual 12. Mar 20 12. Mar 20 119,048 €1.37 €163,252
18. Mar 20 Buy Ian Ainsworth Individual 12. Mar 20 12. Mar 20 119,048 €1.37 €163,252
X
Management checks
We assess kneat.com's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. kneat.com has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

FOBK News

Simply Wall St News

FOBK Company Info

Description

kneat.com, inc. designs, develops, and supplies software for data and document management within regulated environments in the United States, the United Kingdom, Romania, Ireland, and Canada. The company offers Kneat Gx platform, a configurable commercial off-the-shelf application focused on validation lifecycle management and testing for modelling regulated data intensive processes for biotechnology, pharmaceutical, and medical device manufacturing industries. It also provides maintenance, consulting, training, and other services. The company is headquartered in Limerick, Ireland.

Details
Name: kneat.com, inc.
FOBK
Exchange: DB
Founded:
CA$71,500,749
67,598,605
Website: http://www.kneat.com
Address: kneat.com, inc.
Castletroy Park Business Centre,
Unit 7,
Limerick,
Co. Limerick, V94 KW28,
Ireland
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSXV KSI Common Shares TSX Venture Exchange CA CAD 28. Jun 2016
OTCPK FBAY.F Common Shares Pink Sheets LLC US USD 28. Jun 2016
DB FOBK Common Shares Deutsche Boerse AG DE EUR 28. Jun 2016
Number of employees
Current staff
Staff numbers
60
kneat.com employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/03/30 23:49
End of day share price update: 2020/03/30 00:00
Last estimates confirmation: 2020/03/25
Last earnings filing: 2019/11/26
Last earnings reported: 2019/09/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.